Complications and Symptom Management Across the Spectrum of CKD
These modules address complications and symptoms experienced by patients with advanced chronic kidney disease and considerations as their kidney disease progresses and they transition to dialysis and kidney transplant. Specific management of complications in individuals with kidney failure requiring dialysis and kidney transplant will be covered in a separate series of modules. The patient's perspective will be emphasized throughout these modules.
Cases will be used throughout to provide more application based learning opportunities. Each module will include at least one case threaded throughout with self-assessment questions.
Additional modules in this course will be released in 2025.
Course Modules
Displaying 1 - 2 of 2 modules
Anxiety and depression are highly prevalent in chronic kidney disease. In recent years, we’ve learned that response to antidepressants is different in patients with kidney disease. This, coupled with altered medication risk profiles due to declining kidney function, makes management of anxiety and depression a considerable challenge. This module provides an overview of pharmacologic and non-pharmacologic treatment options for anxiety and depression unique to patients with kidney disease.
By the end of this module, learners will be able to:
- Describe prevalence of depression compared to the general population
- Review risk factors for depression
- Discuss non-pharmacologic and preferred pharmacologic options for treating depression and anxiety
- Review the pharmacokinetics and pharmacodynamics of commonly used antidepressants
- Create a treatment plan to select, initiate, adjust, and/or modify pharmacologic agents used in management of depression and anxiety
Pain is one of the most prevalent and problematic somatic symptoms in patients with kidney disease that contributes to poor quality of life. Medication options are limited by declining kidney function. This module is designed to equip clinicians with the tools needed to adequately address pain management in patients with chronic kidney disease using a holistic approach.
By the end of this module, learners will be able to:
- Describe etiologies and types of pain in patients with CKD
- Discuss the pharmacokinetics and pharmacodynamics of analgesics that could be altered in patients with reduced kidney function
- Discuss non-pharmacologic and preferred pharmacologic options to manage pain in CKD, and develop an individualized plan to manage pain in CKD
- Design a monitoring plan to evaluate the efficacy and side effects of therapeutic options
These modules address complications and symptoms experienced by patients with advanced chronic kidney disease and considerations as their kidney disease progresses and they transition to dialysis and kidney transplant. Specific management of complications in individuals with kidney failure requiring dialysis and kidney transplant will be covered in a separate series of modules. The patient's perspective will be emphasized throughout these modules.
Cases will be used throughout to provide more application based learning opportunities. Each module will include at least one case threaded throughout with self-assessment questions.
Additional modules in this course will be released in 2025.
Course Modules
Anxiety and depression are highly prevalent in chronic kidney disease. In recent years, we’ve learned that response to antidepressants is different in patients with kidney disease. This, coupled with altered medication risk profiles due to declining kidney function, makes management of anxiety and depression a considerable challenge. This module provides an overview of pharmacologic and non-pharmacologic treatment options for anxiety and depression unique to patients with kidney disease.
By the end of this module, learners will be able to:
- Describe prevalence of depression compared to the general population
- Review risk factors for depression
- Discuss non-pharmacologic and preferred pharmacologic options for treating depression and anxiety
- Review the pharmacokinetics and pharmacodynamics of commonly used antidepressants
- Create a treatment plan to select, initiate, adjust, and/or modify pharmacologic agents used in management of depression and anxiety
Pain is one of the most prevalent and problematic somatic symptoms in patients with kidney disease that contributes to poor quality of life. Medication options are limited by declining kidney function. This module is designed to equip clinicians with the tools needed to adequately address pain management in patients with chronic kidney disease using a holistic approach.
By the end of this module, learners will be able to:
- Describe etiologies and types of pain in patients with CKD
- Discuss the pharmacokinetics and pharmacodynamics of analgesics that could be altered in patients with reduced kidney function
- Discuss non-pharmacologic and preferred pharmacologic options to manage pain in CKD, and develop an individualized plan to manage pain in CKD
- Design a monitoring plan to evaluate the efficacy and side effects of therapeutic options
